An increased leptin–adiponectin ratio was associated with an increased risk of some types of cancer [108,115] such as breast cancer [113,116], endometrial cancer [114], colorectal cancer [117], pancreatic cancer [118], and prostate cancer [119]. Here, LEP is linked to pancreatic neoplasm.